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Summary
We have examined oocytes from a patient with Kearn-
Sayre syndrome caused by mtDNA rearrangements. In
mtDNA diseases, mutant and wild-type mtDNA fre-
quently coexist in affected individuals (the condition of
heteroplasmy). The proportion of mutant mtDNA trans-
mitted from mother to offspring is variable because of
a genetic bottleneck, and the “dose” of mutant mtDNA
received influences the severity of the phenotype. The
feasibility of prenatal diagnosis is critically dependent
on the nature and timing of this bottleneck. Significant
levels of rearranged mtDNA were detectable in the ma-
jority of the patient’s oocytes, by use of multiplex PCR,
with wide variation, in the levels of mutant and wild-
type molecules, between individual oocytes. We also
used length variation in a homopolymeric C tract, which
is often heteroplasmic in normal controls, to identify
founder subpopulations of mtDNAs in this patient’s oo-
cytes. We present direct evidence that the number of
segregating units (n) is three to five orders of magnitude
less than the number of mitochondria in the human fe-
male oocyte. In some cases, the best estimate of n may
correspond to a single mitochondrion, if it is assumed
that intergenerational transmission of mtDNA can be
treated as a single sampling event. The bottleneck ap-
pears to contribute a major component of the variable
transmission from mother to oocyte, in this patient and
in a control. That this bottleneck had occurred by the
time that oocytes were mature advances the prospects
for prenatal diagnosis of mtDNA diseases.
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Introduction
The transmission of human mtDNA variants is poor-
ly understood (Lightowlers et al. 1997). There are
thousands of copies of mtDNA in a cell, and yet, usually,
the overwhelming majority of mtDNAs in an individual
human are identical (homoplasmy). When there is a
point-mutation difference between a mother and her off-
spring, there may be a complete switch of mtDNA type
within a single generation (a bottleneck). This implies
that a small number of founder mtDNAs populate the
organism.
The wide variation in the level of mutant mtDNAs
transmitted to the heteroplasmic offspring impedes ge-
netic counseling and prenatal diagnosis in families with
heteroplasmic mtDNA point mutations. For example,
the level of 8344G:C mutant mtDNA ranged from 0%
to 73% in the blood of the offspring of an asymptomatic
mother with 14% mutant mtDNA in muscle (Larsson
et al. 1992). This variation in proportion of mutant
transmitted could arise from two sources: random seg-
regation of a specific number of founder mtDNAs (i.e.,
a bottleneck) or nonrandom proliferation of a subpo-
pulation because of some selective advantage that ap-
pears to be rare before birth (Suomalainen et al. 1993;
Matthews et al. 1994). Hauswirth and Laipis (1985; also
see Laipis et al. 1988) investigated a herd of Holstein
cows for a common polymorphism. When there was a
point-mutation difference between a mother and her off-
spring, each could be homoplasmic with respect to that
base. Because oocytes contain ∼100,000 mtDNAs,
Hauswirth and Laipis suggested that only a small num-
ber (n) of mtDNAs ultimately populated the organism
(in a “single selection” model, in which it is assumed
that there is a single restriction/amplification event or
bottleneck). By analysis of the individuals in which the
switching was not complete, they were able to estimate
that and that the segregating unit might be an  1–6
single mitochondrion (Hauswirth and Laipis 1985). This
bottleneck appears to be necessary for maintenance of
homoplasmy.
We have shown elsewhere that individual human oo-
cytes can be heteroplasmic for length variants in a hom-
opolymeric C tract in the vicinity of bp 310 in the major
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noncoding region of mtDNA. Tissues from normal in-
dividuals possessed one major length variant (195%),
but among somatic tissues in any control individual there
was no difference in the pattern of the length variants
when bulk samples were taken. In two normal controls,
the major length variants differed among oocytes from
the same donor, suggesting that segregation of founder
mtDNA molecules had occurred by the time that the
oocytes were mature (Marchington et al. 1997). This
result is consistent with animal data (Jenuth et al. 1996).
In this report, we have analyzed the variance in individ-
ual oocytes from a patient with rearrangements of
mtDNA, compared with that in a control, to estimate
the most likely size of the genetic bottleneck, and we
have found that the number of segregating units (n)
could be as low as a single mitochondrion.
Subjects, Material, and Methods
Human Subjects
The patient in the present study had Kearn-Sayre syn-
drome (KSS) and rearranged mtDNA, comprising du-
plications, deletions, and deletion dimers, in addition to
wild-type molecules (Poulton et al. 1995). The control
was attending an infertility clinic. The study was ap-
proved by the Central Oxfordshire Ethics Committee.
Three-Way PCR to Quantitate mtDNA Rearrangements
All three primers (tRNA Y, corresponding to bp
5864–5883; CO1/5R, reverse and complementary to bp
6154–6135; and Cytb3, reverse and complementary to
bp 15151–15132) were added to each reaction. Ampli-
fication conditions were 94C for 5 min, 55C for 1 min,
and 72C for 1 min (cycle 1) and then 94C for 1 min;
55C for 1 min and 72C for 1 min (39 cycles); and then
72C for 9 min, after the last cycle. PCR was performed
on DNA from different tissues (brain cortex, heart,
ovary, liver, cerebellum, kidney, pituitary, and pancreas)
from patient 1, and the products were labeled by last-
cycle labeling with a[32P]-dCTP. The products were run
on 6% acrylamide gels and were vacuum dried, and the
ratio of the two bands was quantitated on a Phosphor-
imager. Interassay variability typically was 1%.
Three-Way PCR of Single Oocytes from Patient 1
Five-millimeter sections of frozen ovary were placed
in sterile PBS and were allowed to come to room tem-
perature. The sections were washed in sterile PBS, and
the tissue was teased apart by use of sterile scalpel blades,
under a dissectingmicroscope. The oocytes releasedwere
placed in fresh PBS and were examined by light mi-
croscopy. Any that were damaged or that had adherent
cells were discarded. Oocytes were lysed by being boiled
for 10 min in 20 ml of PBS, and 1/10 of the lysate was
taken for PCR. Three-way PCR analysis was performed
on 15 oocytes and the bulk ovarian tissue from which
they were derived. The relationship of three-way PCR
versus Southern blot data from tissues (fig. 1B) was used
to derive the relative proportions of rearranged andwild-
type molecules in individual oocytes, by use of a curve
derived from standards in a range of dilutions (spanning
the template concentration in oocytes) that were am-
plified in the same run. Duplicate determinations on sin-
gle oocytes varied by 0.75%. Because the three-way
PCR did not distinguish between the different rearrange-
ments, three ratios were calculated for each oocyte: the
percentage of mutant when it was assumed that all re-
arrangements were (1) deletion monomers (shown in
table 1), (2) deletion dimers (see Statistical Analysis sub-
section), and (3) duplications (see Statistical Analysis
subsection).
Statistical Analysis
The data obtained were analyzed as described else-
where (Bendall et al. 1996), to infer the size of the in-
tergenerational bottleneck (n), on the assumption that
it represents a one-time sampling (i.e., single selection)
of a small number of mtDNAs from a large pool. In this
approach, Bayes’s theorem is used to evaluate the pos-
terior probability of n, given the observed proportions
of the heteroplasmic variants in ovary/blood and oo-
cytes, and the estimated experimental error in these pro-
portions. The patient’s ovary contained 84% wild-type,
3% deletion-monomer, 5% deletion-dimer, and 8% du-
plicated molecules (by Southern blot). For the purposes
of the calculations, we chose to assume that all the mu-
tant molecules were of the same rearrangement. On the
basis of the ratio of the PCR products for ovary and
oocytes, the plot in figure 1B was used to estimate the
proportion of mutant molecules, on the assumption that
all rearrangements were deletion monomers. Similar re-
sults were obtained if it was assumed that they were
deletion dimers or duplications. In order to apply the
method of Bendall et al. (1996) in the case of the length
variation, variants were pooled into two classes, con-
sisting of the major length variant in the ovary and of
the rest. From the posterior distribution, we quote the
most probable n and the central 95% confidence interval
(95% CI) region. This analysis assumes that, once gen-
erated, the rearrangements and length variants are sta-
ble. Our results represent maximum estimates of n, since
a significant rate of intermolecular conversion (homol-
ogous recombination and generation of new length var-
iants [Marchington et al. 1997], respectively) would re-
sult in overestimates of n (Bendall and Sykes 1995).
In addition, a standard population-genetic equation
for the variance in proportion on repeated sampling (Nei
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Figure 1 A, Location of primers on patient 1’s rearranged mtDNAmolecules. Patient 1 had three distinct but related types of rearrangement
in addition to the wild type (top): a direct tandem duplication (middle), a deletion monomer (bottom left), and deletion dimers (bottom right).
The breakpoint is at bp 6130–15056. The thinner line represents the deleted region, and the thicker line, which includes the large noncoding
region and heavy-strand origin (O), represents the duplicated region (Poulton and Holt 1994). All the mutant molecules contain one or more
abnormal junctions (one in duplicated and deletion monomer molecules and two in deletion dimers). Primers were designed to produce a product
of 350 bp across the junction (tRNA Y and [Cyt]b3) but no product in the wild type. A third primer (CO1/5R) gives a 298-bp product in wild-
type and duplicated mt DNA (which contains a complete wild-type molecule). B, Quantitation of rearranged mtDNAs by PCR. The ratio of
the bands that would be expected on the basis of the known quantities of the different mtDNA forms, as demonstrated by Southern blot analysis
of eight tissues (i.e., wild-typeduplication, vs. duplicationdeletion monomer2# deletion dimer), was calculated and plotted against the
value obtained by the three-way PCR analysis of these tissues. The .97 correlation coefficient demonstrates that the PCR method reflects the
relative quantities of the different molecules present. C, Three-way PCR of single oocytes from patient 1. Three-way PCR was used to quantitate
the proportion of wild type to mutant, both in 15 single oocytes from patient 1 and in the bulk ovarian tissue from which they were derived,
as well as in DNA from a wild-type control. The upper band represents the 350-bp product amplified from mutant molecules, and the lower
band represents the 298-bp product amplified from wild-type or duplicated molecules.
1987, p. 359; Solignac et al. 1987) was used to estimate
the bottleneck size, on the assumption that there were
23 resamplings (Jenuth et al. 1996) (“repeated selec-
tion”). This approach requires an assignment of p0, the
initial proportion of mutant DNA. We derived this from
the proportion identified in ovary, ,21.9% 0.61%
which was not significantly different from the mean pro-
portion in the oocytes, .19.7% 3.05%
Results
The patient in the present study had KSS and rear-
ranged mtDNA comprising duplications, deletions, and
deletion dimers in addition to wild-type molecules (Poul-
ton et al. 1995) (see fig. 1A). Since, apart from rare
exceptions (Bernes et al. 1993; Poulton and Holt 1994),
the majority of mtDNA rearrangements are sporadic,
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Table 1
Estimation of Bottleneck Size in Oocytes from
Patient 1, Based on Mutant Level (Oocytes 1–15)









1 26 114 to 1100 19.3
2 9 18 to 1100 22.2
3 4 13 to 1100 24.4
4 31 24 to 45 48.6
5 21 18 to 42 47.7
6 8 16 to 1100 12.3
7 16 110 to 1100 18.7
8 12 10 to 72 8.5
9 9 17 to 1100 11.3
10 1 1 to 15 .0
11 1100 110 to 1100 22.1
12 4 13 to 1100 25.0
13 8 16 to 1100 13.2
14 10 17 to 1100 9.4
15 8 16 to 1100 12.8
16 6 5 to 68 NA
17 6 5 to 68 NA
18 11 8 to 31 NA
19 10 2 to 23 NA
a All rearrangements are considered to be deletion
monomers. NA not available.
Figure 2 Quantitation of length variation in the D310-tract T-
PCR, used to quantitate the proportion of different length variants in
four oocytes (oocytes 16–19; see table 1) in the homopolymeric C tract
in the vicinity of bp 310, as described elsewhere (Marchington et al.
1997). The intensity of signal in each band on the autoradiograph
represents the proportion of the corresponding length variant. Three
of the four oocytes (lanes 2–4) have the same modal length variant as
is seen in ovarian tissue (i.e., variant 3; frequencies are 82.9%, 84.5%,
and 91.2%, respectively, vs. 65.7% in ovarian tissue), whereas the
fourth has a markedly different pattern of length variants.
the patient had been counseled that the recurrence risk
was low. Single oocytes were dissected from the frozen
postmortem ovary of the patient. The size of the bot-
tleneck was estimated by use of two independent meth-
ods. First, the differences in the levels of the different
mutant molecules (Poulton et al. 1995) was used as the
basis to develop a quantitative, PCR-based analysis of
the level of mutant molecules in single oocytes (fig. 1A
and B). Fifteen different oocytes were investigated for
the presence of rearranged mtDNAmolecules. Figure 1C
demonstrates that there was a wide range in the level of
mutant molecules, relative to that in bulk ovarian tissue.
Rearranged mtDNA molecules were detectable by PCR
in 14 of 15 oocytes from the patient with KSS. Of the
15 oocytes, 3 (20%) (oocytes 8, 10, and 14) contained
!10% mutant mtDNA, whereas the other 12 contained
proportions !50% (mean 23%). Had the oocytes been
viable, this patient might have been able to transmit the
disorder to her offspring. Patients with mtDNA dupli-
cations may have a propensity for germ-line transmis-
sion of mtDNA rearrangements (Poulton and Holt
1994).
In the second method, heteroplasmic length variation
in a homopolymeric tract in the vicinity of bp 310 (i.e.,
the D310 tract) was investigated in the same patient. In
contrast to what was observed for the homopolymeric
C tract in the vicinity of bp 16189 (Bendall and Sykes
1995), individual length variants in this tract segregate
stably with mtDNA subpopulations (Marchington et al.
1997). Four single oocytes were dissected from this pa-
tient and were amplified by trimmed-PCR, as described
elsewhere (Marchington et al. 1997). The size of the
a[32P]-labeled single-stranded product is representative
of the length of the homopolymeric tract and was used
to quantitate length variants after they were run on a
sequencing gel and were subjected to Phosphorimager
analysis. Figure 2 shows that all four oocytes were het-
eroplasmic for D310-tract length variation. In three of
the oocytes (oocytes 16–18 in table 1) the major length
variant was the same as that in the ovarian tissue from
which they were obtained, but in the fourth oocyte (oo-
cyte 19) the major length variant was different.
We now have analyzed these data through a Bayesian
approach (Bendall et al. 1996), which assumes that a
small sample from a large number of mtDNAs is with-
drawn at random at one time point during oocyte mat-
uration (i.e., the single-selection model). On the basis of
the first approach (which uses the proportion of rear-
ranged molecules), we estimated that the most probable
bottleneck size is 1–31 segregating units (95% CI 
1–65 segregating units). The modal most probable nwas
8 (in 3 of 15 oocytes), and the median was 9. This
estimate was barely altered despite any assumptions
made about the type of rearranged molecule in the oo-
cyte (see the Subjects, Material, and Methods section).
When the calculations were based on D310-tract length
variation, the most probable bottleneck size was 6–11
(95% CI  2–68). The magnitude of the bottleneck is
similar in both patient and a control in whom the most
probable n was 1–5 (95% CI  1–6) (tables 1 and 2).
By use of the same equation as was used by Jenuth et
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Table 2
Estimation of Bottleneck Size in
Oocytes from a Control (Subject 10 in











al. (1996), we calculate that, in the patient, the number
of segregating units may be 9 (in single selection) or 210
(in repeated selection, on the basis of 23 cell divisions).
Discussion
The estimates of bottleneck size are similar whether
rearrangements or the D310 tract is used. Taken to-
gether, these two approaches strongly suggest that a
mtDNA bottleneck had occurred by the time that this
patient’s oocytes were mature, as we had observed ear-
lier in human controls (Marchington et al. 1997). This
is consistent with data on PCR of oocytes carrying the
8993 mutation (Blok et al. 1997). The occurrence of the
major component of mtDNA bottleneck before fertili-
zation suggests that the proportion of mutant mtDNA
in a chorionic villus sample may be representative of the
level in the rest of the conceptus. Although it is clear
that segregation of mtDNA mutants occurs postnatally
(Matthews et al. 1994; Poulton and Morten 1993) and
in tissue culture (Dunbar et al. 1995), we consider that
the present results improve the prospects for prenatal
diagnosis.
Other investigators have estimated the number of seg-
regating units either on the basis of indirect observations
of intergenerational variance (Bendall et al. 1996) or,
more directly, on the basis of the variance in hetero-
plasmic mouse oocytes (Jenuth et al. 1996). In a study
of blood DNA from 180 twin pairs, Bendall et al. (1996)
identified heteroplasmy in four families and demon-
strated both very small and large swings in genotypic
ratio, between generations (Bendall et al. 1996). Esti-
mates of n varied for each mother-child pair but ranged
from 2 to 1100. Overall, the best estimate was ∼3–20,
consistent with the results from our study of control
oocytes, by use of a single-selection model. However,
others have derived higher estimates, by use of a re-
peated-selection model, which assumes that there may
be multiple bottlenecks between generations (Howell et
al. 1992).
Jenuth et al. (1996) have constructed a heteroplasmic
mouse model of mtDNA segregation by introducing do-
nor cytoplasm into a fertilized recipient egg (Jenuth et
al. 1996). They investigated the variance of the propor-
tions of donor mtDNA at different developmental
stages. They found that the variance increase between
primordial germ cells and primary oocytes was greater
than that at later stages of developing oocytes and prog-
eny. Consistent with our findings, these data suggest that
a major component of the mtDNA bottleneck has oc-
curred by the time that oocytes are mature. However,
Jenuth et al. (1996) have estimated that the number of
segregating units is ∼200, which is 7–200-fold greater
than our estimates, in humans, on the basis of a single-
selection model. Clearly, there may be a species differ-
ence, but the major difference relates to the mathemat-
ical model used. Thus, the model used by Jenuth et al.
(1996) assumes that the variance in genotypic ratios of
the progeny or developing oocytes is caused by an iden-
tical random-sampling event that occurs during each of
the 15 or so cell divisions during the later stages of
oogenesis (i.e., repeated selection), in contrast to a more
dramatic reduction in segregating units during a briefer
period (i.e., single selection). Substituting a single selec-
tion (rather than 15) in their equation, we obtain, on
the basis of their data, a bottleneck size of 6–60, which
overlaps with the 1–31 derived from our data. When
subjected to the same equation as was used by Jenuth
et al., our data suggest that, in the patient with mito-
chondrial disease, the number of segregating units may
be 9 (in single selection) or 210 (in 23 selections, which
is based on an estimate of the number of cell divisions
in human oogenesis). Hence, the choice of model used
generates an ∼23-fold difference in the size of n.
Are there any additional data that favor either one of
the models? Blok et al. (1997) have concluded that their
data on skewing of oocytes to wild type or mutant was
not compatible with a conventional bottleneck model
(they calculated that n was 120, on the basis of a re-
peated-selection analysis). They do not present sufficient
data to allow full recalculation with use of our model.
However, if we consider their oocytes to be virtually
homoplasmic, then the most likely bottleneck size is 1.
Hence, a single-selection model is more suitable for the
data of Blok et al. (1997). Theoretically, the shape of
the distributions generated by the alternative models
(i.e., the frequency of oocytes containing different per-
centages of mtDNA mutant) might allow one to deter-
mine which of the two models fits the data best (Poulton
et al. 1998). The repeated-selection model generates dis-
tributions that are peaked at fixation for mutant and
wild-type mtDNA (Preiss et al. 1995), whereas a single-
selection model generates a binomial distribution. At
low percentages of mutants, the shape of these two dis-
tributions is similar (Poulton et al. 1998), although at
higher maternal levels of mutant it might be possible to
distinguish between them.
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Most of the 50-fold expansion in the number of
mtDNAs—to 100,000/cell, in the development from pri-
mordial germ cells to mature oocyte—occurs after the
final cell division. Hence, a repeated-selectionmodelmay
be inappropriate, because it assumes 23 or so identical
cell divisions. There is morphological evidence for dis-
tinct subpopulations of mitochondria during the devel-
opment of human oocytes, and in Xenopus the mtDNA
in one subgroup replicates faster than that in the other
subgroup (Tourte et al. 1984). Similarly, it has been sug-
gested that, in cultured human cells (Davis and Clayton
1996) and in early mouse embryos (Meirelles and Smith
1998), mtDNA in the mitochondria lying in close prox-
imity to the nucleus may replicate faster than those at
the periphery. Although there are no equivalent data on
human oocytes, a small subpopulation of mtDNAs that
replicate repeatedly might underlie the massive expan-
sion in mtDNA during oocyte maturation. If so, this
may fit the single-selection model more closely than it
fits the repeated-selection model. In mtDNA diseases,
the apparent bottleneck size may depend on the char-
acteristics of the pathogenic mutation (Blok et al. 1997).
It may be necessary to make a new estimate of the bot-
tleneck size, in order to counsel each individual family.
If so, a single-selection model is more usable (Poulton
et al. 1998) and may describe the data more accurately
(Blok et al. 1997), even if a repeated-selection model is
more representative of the number of cell divisions dur-
ing oogenesis. Bottleneck sizes could be used to improve
calculations of personalized recurrence risks (Poulton et
al. 1998).
Whichever model is used, it is clear that the number
of segregating units in the female germ line is three to
five orders of magnitude less than the number of mi-
tochondria in the mature human ovum. Maintenance of
homoplasmy may protect against the development of
mtDNA disease. A tight mtDNA bottleneck thus may
be a necessary solution to the accumulation of somatic
mutations of mtDNA during the aging process (Corto-
passi et al. 1992), an accumulation that also occurs in
oocytes (Chen et al. 1995).
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